Your browser doesn't support javascript.
loading
Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity.
Tanaka, Shinya; Ise, Wataru; Inoue, Takeshi; Ito, Ayako; Ono, Chisato; Shima, Yoshihito; Sakakibara, Shuhei; Nakayama, Manabu; Fujii, Kentaro; Miura, Ikuo; Sharif, Jafar; Koseki, Haruhiko; Koni, Pandelakis A; Raman, Indu; Li, Quan-Zhen; Kubo, Masato; Fujiki, Katsunori; Nakato, Ryuichiro; Shirahige, Katsuhiko; Araki, Hiromitsu; Miura, Fumihito; Ito, Takashi; Kawakami, Eiryo; Baba, Yoshihiro; Kurosaki, Tomohiro.
Afiliación
  • Tanaka S; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Ise W; Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
  • Inoue T; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Noda, Japan.
  • Ito A; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Ono C; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Shima Y; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Sakakibara S; Division of Immunology and Genome Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
  • Nakayama M; Laboratory of Thermo-Therapeutics for Vascular Dysfunction, Osaka University, Suita, Japan.
  • Fujii K; Laboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Miura I; Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Kisarazu, Japan.
  • Sharif J; Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Koseki H; Technology and Development Team for Mouse Phenotype Analysis, RIKEN BioResource Research Center, Tsukuba, Japan.
  • Koni PA; Laboratory of Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Raman I; Laboratory of Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Li QZ; Advanced Research Departments, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kubo M; Georgia Cancer Center, Augusta University, Augusta, GA, USA.
  • Fujiki K; Microarray Core Facility, Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Nakato R; Microarray Core Facility, Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Shirahige K; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Noda, Japan.
  • Araki H; Laboratory for Cytokine Regulation, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Miura F; Institute of Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.
  • Ito T; Institute of Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.
  • Kawakami E; Institute of Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.
  • Baba Y; Department of Biochemistry, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kurosaki T; Department of Biochemistry, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nat Immunol ; 21(8): 950-961, 2020 08.
Article en En | MEDLINE | ID: mdl-32572241
ABSTRACT
A contribution of epigenetic modifications to B cell tolerance has been proposed but not directly tested. Here we report that deficiency of ten-eleven translocation (Tet) DNA demethylase family members Tet2 and Tet3 in B cells led to hyperactivation of B and T cells, autoantibody production and lupus-like disease in mice. Mechanistically, in the absence of Tet2 and Tet3, downregulation of CD86, which normally occurs following chronic exposure of self-reactive B cells to self-antigen, did not take place. The importance of dysregulated CD86 expression in Tet2- and Tet3-deficient B cells was further demonstrated by the restriction, albeit not complete, on aberrant T and B cell activation following anti-CD86 blockade. Tet2- and Tet3-deficient B cells had decreased accumulation of histone deacetylase 1 (HDAC1) and HDAC2 at the Cd86 locus. Thus, our findings suggest that Tet2- and Tet3-mediated chromatin modification participates in repression of CD86 on chronically stimulated self-reactive B cells, which contributes, at least in part, to preventing autoimmunity.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Autoinmunidad / Proteínas Proto-Oncogénicas / Dioxigenasas / Proteínas de Unión al ADN / Antígeno B7-2 Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Autoinmunidad / Proteínas Proto-Oncogénicas / Dioxigenasas / Proteínas de Unión al ADN / Antígeno B7-2 Límite: Animals Idioma: En Año: 2020 Tipo del documento: Article